INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Derivative conversionVerified dataRule 10b5-1 plan

Schlosser Mario reported OSCR

Director, President of Technology & CTO · Oscar Health, Inc. · Oscar Health, Inc. — Class B Common Stock

Side
C
Value
—
Shares
77.0K
Price
—
Executed
Jan 6, 2026
Disclosed
Jan 8, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 6 executedJan 8, 2026 disclosed

OSCR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Derivative conversion — administrative, little informational value

  • Relative size+5 / 25

No reported dollar value · 5.6% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    4 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · OSCR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    GW
    Gassen WilliamDirector
    OSCROscar Health, Inc.
    Grant or award
    		A$23K
    698 sh
    		Oct 8, 2026Oct 13, 2026
    traded Oct 8, 2026
    		+5dSEC FORM 4

    Evidence

    19
    PD
    Plouffe DavidDirector
    OSCROscar Health, Inc.
    Grant or award
    		A$21K
    641 sh
    		Oct 8, 2026Oct 13, 2026
    traded Oct 8, 2026
    		+5dSEC FORM 4

    Evidence

    23
    MA
    McAnaney AdamChief Legal Officer
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$286K
    9,092 sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    24
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$988K
    31.4K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    17
    BV
    Baltrus VictoriaChief Accounting Officer
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$30K
    958 sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    48
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale
    		SELL$18.20M
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    6
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    15
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M$1.46M
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    19
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M$5.85M
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    10
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    41
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale
    		SELL$4.62M
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    6
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    14
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    14
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    10
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    1
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$54K
    1,799 sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise · 10b5-1 plan
    		M$6.43M
    660.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    4
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    880.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    50.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    50.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001844320-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 6, 2026
    Published
    Jan 8, 2026
    Ingested by INSIDER
    Nov 5, 04:23 UTC
    Last re-read
    Nov 5, 04:23 UTC

    Extracted facts

    Filer
    Schlosser Mario
    Role
    Director, President of Technology & CTO
    Transaction
    Derivative conversionAs filed: “C”
    Asset
    Oscar Health, Inc. — Class B Common Stock
    Ticker
    OSCR
    Shares
    77.0K
    Price per share
    $0
    Execution date (reported)
    Jan 6, 2026
    Owned after transaction
    1.46M shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    What this establishes

    Schlosser Mario filed this Form 4 reporting a derivative conversion of OSCR on Jan 6, 2026. It became public on Jan 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, President of Technology & CTO
    Schlosser Mariocik:0001844320
    Issuer
    Oscar Health, Inc.cik:0001568651

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.